Databases

An initiative of JNCCN is JNCCN 360, which is a comprehensive, primarily tumor-specific online news source geared for a broad audience of oncology professionals.  The assortment of microsites covers disease states from solid tumors such as breast and prostate cancers to hematologic malignancies such as multiple myeloma.  Content curation and development is overseen by NCCN Guidelines Panel Members.

JNCCN 360 microsites can be accessed at https://jnccn360.org/ and contain the following features:

• Latest oncology news from medical meetings and the U.S. Food & Drug Administration
• Key clinical trial findings and more from the medical literature
• Featured content including original research and NCCN Guidelines Insights
• Video interviews with leading oncology experts
• JNCCN Spotlights—original feature articles on specific oncology drugs with clinical pearls from colleagues on how best to use them effectively and safely in practice
• Ongoing continuing education activities, available clinical trials, and patient resources

The NCCN Guidelines® are a comprehensive set of guidelines detailing the sequential management decisions and interventions that currently apply to 97 percent of cancers affecting patients in the United States.

*Create an account for free.